Antigenic and Sequence Diversity in Gonococcal Transferrin-Binding Protein A by Cornelissen, C. N. et al.
INFECTION AND IMMUNITY,
0019-9567/00/$04.0010
Aug. 2000, p. 4725–4735 Vol. 68, No. 8
Copyright © 2000, American Society for Microbiology. All Rights Reserved.
Antigenic and Sequence Diversity in Gonococcal
Transferrin-Binding Protein A
CYNTHIA NAU CORNELISSEN,1* JAMES E. ANDERSON,2 IAN C. BOULTON,1†
AND P. FREDERICK SPARLING2,3
Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University,
Richmond, Virginia 23298,1 and Departments of Medicine2 and Microbiology and Immunology,3
School of Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599
Received 10 March 2000/Returned for modification 21 April 2000/Accepted 12 May 2000
Neisseria gonorrhoeae is a gram-negative pathogen that is capable of satisfying its iron requirement with
human iron-binding proteins such as transferrin and lactoferrin. Transferrin-iron utilization involves specific
binding of human transferrin at the cell surface to what is believed to be a complex of two iron-regulated,
transferrin-binding proteins, TbpA and TbpB. The genes encoding these proteins have been cloned and
sequenced from a number of pathogenic, gram-negative bacteria. In the current study, we sequenced four
additional tbpA genes from other N. gonorrhoeae strains to begin to assess the sequence diversity among
gonococci. We compared these sequences to those from other pathogenic bacteria to identify conserved regions
that might be important for the structure and function of these receptors. We generated polyclonal mouse sera
against synthetic peptides deduced from the TbpA sequence from gonococcal strain FA19. Most of these
synthetic peptides were predicted to correspond to surface-exposed regions of TbpA. We found that, while most
reacted with denatured TbpA in Western blots, only one antipeptide serum reacted with native TbpA in the
context of intact gonococci, consistent with surface exposure of the peptide to which this serum was raised. In
addition, we evaluated a panel of gonococcal strains for antigenic diversity using these antipeptide sera.
Virtually all microorganisms require iron as a cofactor for
various enzymatic processes (8). Because free iron concentra-
tions are low in oxygenated environments at neutral pH (44)
and in plant and animal hosts (55), microbes have evolved
intricate and elegant mechanisms by which they scavenge iron
from their surroundings. The most common method involves
the synthesis of siderophores, which bind iron with high affinity
and specificity (44). The process of iron utilization via a sid-
erophore intermediate requires specific binding of the ferric
siderophore to a surface-exposed receptor (for reviews, see
references 7 and 43). Energy is provided to these TonB-de-
pendent receptors in the form of the proton motive force
through the function of an energy-transducing complex of pro-
teins, TonB, ExbB, and ExbD (28, 30, 48).
As an alternative to siderophore synthesis, some bacteria
have evolved the capacity to utilize host-derived iron sources
by a direct, receptor-mediated mechanism, which is uniquely
adapted to the organism’s preferred host (for reviews, see
references 18 and 24). For example, Actinobacillus pleuropneu-
moniae, a porcine pathogen, specifically utilizes iron from por-
cine transferrin (21), whereas Neisseria gonorrhoeae, a strict
human pathogen, binds and utilizes the iron specifically from
human transferrin (5, 33). N. gonorrhoeae and its close relative
Neisseria meningitidis also utilize iron bound to human lacto-
ferrin, hemoglobin, and heme (39). Binding of transferrin,
lactoferrin, and hemoglobin to the pathogenic members of the
family Neisseriaceae involves two characterized proteins, one of
which bears a resemblance to TonB-dependent, siderophore
receptors and the other of which is lipidated (1, 3, 4, 6, 15, 34,
35, 47, 54). In the transferrin-iron internalization system, these
two proteins have been designated TbpA and TbpB, respec-
tively. A gonococcal mutant lacking both TbpA and TbpB was
unable to establish an infection or elicit signs or symptoms of
urethritis in a human challenge model of gonococcal infection
(16). Although this result strongly implicates the function of
the gonococcal transferrin receptor in the initial stages of
gonococcal disease, it should be noted that both the tbp
mutant and the wild-type strain (FA1090) used in this study
were incapable of lactoferrin-iron utilization. Anderson and
Sparling have recently created a lactoferrin-positive, trans-
ferrin-negative derivative of FA1090 and are currently testing
this mutant in the human challenge model to elucidate the role
of the lactoferrin receptor in the initiation of urethritis in
human males (unpublished data).
Sequence analysis and functional studies of the transferrin
receptors (for reviews, see references 14 and 18) have led to
the hypothesis that TbpA and TbpB constitute the functional
transferrin receptor, which serves as the first point of contact
between ferrated transferrin and the bacterium. We have sug-
gested that TbpB increases the efficiency of iron uptake from
transferrin by virtue of its specificity for the ferrated ligand (1,
17). Because TbpA is similar to other TonB-dependent recep-
tors, we have proposed that it forms the pore through which
transferrin-bound iron enters the periplasm (15, 18). Recent
crystal structures of two other TonB-dependent receptors (10,
37) described two functional domains within these outer mem-
brane receptors. The first domain represents the amino-termi-
nal third of the protein and includes the so-called TonB box
(53), which has been implicated in a physical association be-
tween TonB and outer membrane receptors (2, 27, 32, 52). In
addition to the TonB box, this amino-terminal domain con-
tains two other regions that are conserved among TonB-de-
pendent receptors (15). The crystal structures of FepA and
FhuA locate this amino-terminal domain not within the plane
* Corresponding author. Mailing address: P.O. Box 980678, Rich-
mond, VA 23298-0678. Phone: (804) 225-4121. Fax: (804) 828-9946.
E-mail: cncornel@hsc.vcu.edu.
† Present address: Department of Medical Genetics and Microbiol-
ogy, University of Toronto, Toronto, Ontario, Canada.
4725
of the membrane, as previous models suggested (31, 41), but
within the lumen of the b-barrel formed by the remaining
two-thirds of the protein. This “plug” (37) or internal “hatch”
(10) is postulated to limit access into the periplasm and opens
only when it simultaneously senses the presence of ligand and
cytoplasmic membrane-derived energy.
The neisserial transferrin receptor is subject to intense scru-
tiny not only to ascertain its mode of operation but also be-
cause both components have become viable vaccine candidates
for immunoprophylaxis against both meningococcal and gono-
coccal disease. The transferrin receptors expressed by N. men-
ingitidis strains have been grouped into two distinct classes
based on molecular weight and sequence heterogeneity (49).
Most strains fall into the high-molecular-weight class, while
approximately a quarter of the strains tested expressed a ver-
sion of TbpB that was significantly smaller. Among a panel of
50 gonococcal strains, all express a TbpB that is closely related
to the high-molecular-weight class of meningococcal TbpBs;
there is no evidence of a low-molecular-weight species of gono-
coccal TbpB (13). The purpose of the current study was to
begin to assess the antigenic and sequence variability of TbpA
species among gonococcal strains, which is a necessary step in
the evaluation of TbpA as a potential vaccine component. We
sequenced four new gonococcal tbpA genes and compared
them to our previously published gonococcal tbpA sequence.
We also compared the gonococcal TbpAs with those from N.
meningitidis, Haemophilus influenzae, A. pleuropneumoniae,
Moraxella catarrhalis, and Pasteurella haemolytica. Sequence
variability among gonococcal TbpAs is likely to be highly rep-
resented in surface-exposed regions, while sequence conserva-
tion among diverse TbpAs might indicate regions that are
structurally or functionally constrained. We generated a set of
antipeptide sera directed at putatively surface-exposed regions
of gonococcal TbpA, which we used to assess the antigenic
diversity within a larger group of gonococcal strains. We found
that, while most of the antipeptide sera reacted with denatured
TbpA, only one serum recognized membrane-bound TbpA,
suggesting that the epitope to which this serum was raised was
surface exposed in the gonococcus.
MATERIALS AND METHODS
Strains and growth conditions. The gonococcal strains used in this study are
described in Table 1. Gonococci were maintained on Bacto GC medium base
(Difco) to which Kellogg’s supplement I (29) and 12 mM Fe(NO3)3 were added.
Plates were incubated at 35°C in a 5% CO2 atmosphere. To induce iron stress,
gonococci were grown in CDM medium (56), to which either no iron or 30%
iron-saturated, human transferrin (2.5 mM) (Sigma Aldrich Chemicals, St. Louis,
Mo.) was added. In other experiments, iron stress was induced by growth of
gonococci on GC medium base plates, to which 10 mM deferoxamine mesylate
(Sigma Aldrich Chemicals) was added in place of the Fe(NO3)3 supplement.
Molecular biological procedures. Primers designed to PCR amplify all or
portions of tbpA genes from FA1090, UU1008, Pgh3-2, and 4102 chromosomal
DNA preparations are as follows. Primers JRW2 (59-CCAAGGCGAGCGCAC
CGATG-39) and TfBP1 (59-GAGCCCGCCAATGCGCCGCT-39) were used to
amplify the 59 portion of tbpA, while TfBP27 (59-CGGTGTATCGGGAAGGA
TGG-39) and TfBP34 (59-GTCGAAATCAGCAAAGGC-39) were used to am-
plify the 39 portion of the gene. In other experiments, we used Hind (59-CGA
AGAGTTGGGCGGATGGTT-39) and oVCU-7 (59-CTCGAGGCTCTAGAA
ACCCCAACGCAG-39) primers to amplify tbpA in its entirety. PCR products
were purified by agarose gel electrophoresis using Magic PCR columns (Pro-
mega, Madison, Wis.) and cloned into the pCRII vector (InVitrogen, San Diego,
Calif.). Pools of 6 to 10 clones for each PCR product were used as sequencing
templates. In some cases, PCR products were not cloned but pooled and se-
quenced directly. Manual sequencing was performed using Sequenase (United
States Biochemical Corporation, Cleveland, Ohio), and automated sequencing
was performed at the University of North Carolina at Chapel Hill Automated
DNA Sequencing Facility on a Model 373A DNA Sequencer (Applied Biosys-
tems, Foster City, Calif.) using a Taq DyeDeoxy Terminator Cycle sequencing kit
(Applied Biosystems). Both strands of the PCR products were sequenced in both
directions using specific primers designed from the FA19 tbpA sequence or using
vector-specific primers. Sequence analysis was performed using the University of
Wisconsin GCG software package (Madison, Wis.) (19). Alignments of the
TbpA sequences were constructed from sequences listed in Table 2 using the
programs PILEUP and PRETTY. The relatedness tree was constructed using
the alignment created by PILEUP and the program GROWTREE.
Antipeptide sera. Eight peptides of 11 to 14 residues in length were synthe-
sized with the sequences highlighted in green in Fig. 1. These peptides were
predicted to be hydrophilic, antigenic, and surface exposed by the program
PLOTSTRUCTURE (Genetics Computer Group, Inc., Madison, Wis.). Pep-
tides were conjugated to Pierce’s SuperCarrier according to the manufacturer’s
recommendations (Pierce, Rockford, Ill.). For each peptide conjugate, five mice
were immunized subcutaneously in Freund’s complete adjuvant and two subse-
quent times in Freund’s incomplete adjuvant. Mice were exsanguinated 12 weeks
after the first immunization. Sera from individual mice were maintained sepa-
rately and screened individually.
Characterization of antipeptide sera. Sera obtained following immunizations
were screened by Western blotting against whole-cell lysates of gonococcal
strains FA19 and FA6815 as previously described (13). Those sera that were
negative by Western blotting for reactivity against wild-type TbpA were screened
by enzyme-linked immunosorbent assay (ELISA) against homologous peptide.
Dilutions of purified peptide were applied to ReactiBind plates (Pierce) accord-
ing to the manufacturer’s recommendations. Dilutions of preimmune sera and
hyperimmune sera were screened for reactivity with each peptide by standard
procedures. All sera were screened for reactivity against whole-cell dot blots of
gonococcal strains FA19 and FA6815 essentially as previously described for
solid-phase, transferrin binding assays (17). Bound polyclonal mouse antibodies






FA19 Wild type 40
FA1090 Wild type 11




Pgh3-2 Wild type 13
FA6642 Wild type 13
4102 Wild type R. Brunham
4121 Wild type R. Brunham
4125 Wild type R. Brunham
4141 Wild type R. Brunham
4146 Wild type R. Brunham
4178 Wild type R. Brunham
4196 Wild type R. Brunham
4134 Wild type R. Brunham
N. meningitidis FAM20 Wild type 20
TABLE 2. tbpA sequences aligned in this study
Strain Organism Referenceor source
Accession
no.
FA19 N. gonorrhoeae 15 M96731
FA1090 N. gonorrhoeae This study AF124339
UU1008 N. gonorrhoeae This study AF124338
Pgh3-2 N. gonorrhoeae This study AF241227
4102 N. gonorrhoeae This study AF240638
M982 N. meningitidis 34 Z15130
B16B6 N. meningitidis 34 Z15129
B:15, P1.16 N. meningitidis Unpublished X75166
MinnA H. influenzae 38 U15052
Eagan H. influenzae 38 U15051
PAK12085 H. influenzae 38 U15053
DL63 H. influenzae type b 23 U10882
h49 A. pleuropneumoniae 22 U16017
h171 A. pleuropneumoniae 22 U16019
Q8 M. catarrhalis 42 AF039312
4223 M. catarrhalis 42 AF039315
h196 P. haemolytica 46 U73302
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FIG. 1—Continued.
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were detected by addition of a secondary goat anti-mouse immunoglobulin G
conjugated to alkaline phosphatase (Sigma Aldrich) followed by development
with nitroblue tetrazolium and BCIP (5-bromo-4-chloro-3-indolylphosphate).
Immunofluorescence microscopy was performed to verify that antiserum against
peptide TbpA-5 bound to surface-exposed epitopes of TbpA on intact gonococci.
Iron-stressed, whole cells from gonococcal strains FA19 and FA6747 were mixed
with dilutions of preimmune and hyperimmune sera along with immunoglobulin-
free bovine serum albumin (Sigma Aldrich) as a nonspecific blocker. Unbound
antibody was removed by centrifugation, and then cells with bound antibody
were applied to glass microscope slides and immersed in 100% methanol for
fixation. Subsequently, slides were probed with a secondary goat anti-mouse
antibody conjugated to fluorescein isothiocyanate (Sigma Aldrich) and cells were
counterstained with Eriochrome Black (Integrated Diagnostics, Baltimore, Md.).
Samples were visualized in an Olympus BHA microscope equipped with a model
BH2RFL reflected fluorescence attachment and a model PM-10AD photomi-
crographic system (Olympus Corp., Melville, N.Y.). Negative controls in these
experiments included probing FA6747 (TbpA2) with antiserum against peptide
TbpA-5 and probing FA19 with preimmune sera. The positive control was FA19
probed with an antiserum raised against gonococcal PorA.
Nucleotide sequence accession numbers. The DNA sequences determined in
this study were reported to the GenBank database under the accession numbers
listed in Table 2.
RESULTS
DNA sequence analysis of tbpA from four gonococcal
strains. The sequences of four gonococcal tbpA genes were
determined to begin to assess the extent of interstrain genetic
variability of this potential vaccine antigen. The predicted pro-
tein sequence of TbpA from gonococcal strain UU1008 was
95.1% identical to the published TbpA sequence (15) from
strain FA19, while the TbpA sequence from FA1090 was
96.2% identical to the FA19 TbpA sequence (Table 3). The
FA1090 TbpA sequence determined in this study was identical
to that identified in the nearly complete, gonococcal genome
sequencing project (B. A. Roe, S. P. Lin, L. Song, X. Yuan, S.
Clifton, T. Ducey, L. Lewis, and D. W. Dyer, Gonococcal
Genome Sequencing Project [http://www.genome.ou.edu/go-
no.html]). TbpAs from gonococcal strains 4102 and Pgh3-2
were likewise very similar to that of FA19, sharing 96.1 and
97.4% identity, respectively. All of the gonococcal TbpA se-
quences were closely related to the TbpA sequences from
meningococcal strains M982 and B:15, P1.16; pairwise identity
scores for these two meningococcal proteins compared with
the gonococcal TbpAs ranged from 93.5 to 95.1% (Table 3). In
contrast, the TbpA sequence from meningococcal strain
B16B6 exhibited only 75.9 to 77% identity compared to the
other neisserial TbpAs (Table 3). Thus, all of the gonococcal
TbpA sequences determined to date closely resemble the
TbpA sequences from meningococcal strains M982 and B:15,
P1.16. Figure 1 depicts a multiple sequence alignment com-
paring the neisserial TbpA proteins determined in this study
with those available in GenBank (Table 2). The residues high-
lighted in blue depict those that are variant among the gono-
coccal TbpAs. These residues appear in clusters highlighting
four hypervariable domains, which correspond to residues 269
to 332, 412 to 447, 583 to 743, and 912 to 929 in the alignment
in Fig. 1.
Comparison between gonococcal TbpAs and TbpAs from
other genera. We also compared the gonococcal TbpA se-
quences determined in this study with those available in Gen-
Bank for H. influenzae, A. pleuropneumoniae, M. catarrhalis,
and P. haemolytica (Table 2). Identical residues in all 17
aligned sequences (Fig. 1) are indicated by an asterisk in the
consensus line, while conserved residues are indicated by a plus
FIG. 1. Multiple sequence alignment of TbpA proteins. The letter preceding the sequence name to the left of each line indicates the species from which the TbpA
sequence was derived: a, N. gonorrhoeae; b, N. meningitidis; c, M. catarrhalis; d, H. influenzae; e, A. pleuropneumoniae; f, P. haemolytica. Boxed single-letter amino acid
designations indicate the mature amino terminus of TbpA, if known. Sequences highlighted in green represent the gonococcal strain FA19 TbpA sequences that were
synthesized as peptides to generate antipeptide sera. These peptides are numbered and labeled TbpA-1 through TbpA-8, consecutively, from amino terminus to carboxy
terminus. Yellow highlighting represents regions homologous to known transmembrane b-strands in E. coli FepA. Blue shading signifies diversity among TbpAs from
five gonococcal strains. Gray shading indicates residues that are unique to TbpAs expressed by the human pathogens. Cysteine residues are highlighted in orange. The
black vertical arrow represents the carboxy-terminal end of the so-called plug region, defined by homology with E. coli FepA. Dots indicate positions in which gaps were
introduced in the alignment; squiggles indicate positions for which no sequence was available. In the consensus line, the asterisks represent complete identity among
all 17 aligned sequences; plus signs indicate conservative replacements at that position in the 17-sequence alignment.
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sign. Due to their maintenance across genera, these conserved
residues are likely to be constrained by the common function,
topology, or assembly of these transferrin receptors. Most of
the conservation among these proteins was confined to narrow
domains that are virtually superimposable with hypothetical
transmembrane b-strands (highlighted in yellow in Fig. 1).
These putative b-strands were identified by constructing a pair-
wise alignment between gonococcal TbpA and the Escherichia
coli ferric enterobactin receptor, FepA, for which the crystal
structure has been determined previously (10). Two other fea-
tures of TbpA were conserved across genus lines. These in-
cluded six paired cysteine residues (orange in Fig. 1), which are
likely to be located in surface-exposed loops (10, 37, 51), and
a 209-residue, amino-terminal domain, which is homologous to
the so-called plug or hatch identified in the E. coli TonB-
dependent receptors (between the amino terminus and the
vertical arrow in Fig. 1). This amino-terminal region not only is
well conserved among the 17 sequences aligned in Fig. 1 but
also contained three of the seven characterized domains that
are shared by all TonB-dependent proteins (15).
Pairwise identity scores between neisserial TbpAs and Tb-
pAs expressed by other genera ranged from 43% in P. haemo-
lytica to 52.6% in H. influenzae (Table 3). Using these pairwise
identity scores, we generated the relatedness tree of TbpA
proteins shown in Fig. 2. This tree reflects the relationship
between TbpAs expressed by different genera and species; it
does not necessarily reflect the overall genetic relatedness be-
tween these organisms. Of particular note was the early
branching between the TbpAs expressed by the animal patho-
gens (A. pleuropneumoniae and P. haemolytica) and by the
human pathogens. TbpAs expressed by M. catarrhalis strains
branched off next, followed by those expressed by H. influenzae
strains. The phylogram in Fig. 2 also emphasizes the genetic
distance between the TbpA from meningococcal strain B16B6
and the rest of the neisserial TbpAs.
Reactivities of antipeptide sera. We initially generated an-
tiserum against eight peptides to test our hypothetical topology
model of gonococcal TbpA (I. C. Boulton, M. K. Yost, J. E.
Anderson, and C. N. Cornelissen, submitted for publication).
Peptides were synthesized with the sequences shown in Fig. 1
and were chosen because they were hydrophilic and predicted
to be surface exposed and antigenic, with the exception of
peptides TbpA-1 and TbpA-2, which were chosen as negative
controls in surface exposure experiments. Antipeptide sera
FIG. 2. Relatedness tree of TbpA proteins. The letter preceding the se-
quence name indicates the species from which the TbpA sequence was derived:
a, N. gonorrhoeae; b, N. meningitidis; c, M. catarrhalis; d, H. influenzae; e, A.
pleuropneumoniae; f, P. haemolytica. The scale bar at the bottom represents 10
substitutions per 100 residues.
TABLE 3. Pairwise alignment scores
Strain
Value for groupa:
a b c d e f
FA19 FA1090 UU1008 4102 Pgh3-2 M982 B:15, P1.16 B16B6 Q8 4223 DL63 PAK MinnA Eagan h49 h171 h196
FA19 97.5 96.7 96.5 97.9 96.2 95.7 85.1 56.2 55.9 60.6 60.2 60.0 60.0 52.9 53.3 52.5
FA1090 96.2 98.8 97.6 96.0 96.6 94.8 80.0 57.1 56.3 60.6 60.8 60.8 60.8 52.8 53.4 52.5
UU1008 95.1 97.3 98.5 96.0 96.9 94.4 85.8 56.6 55.3 60.6 60.7 60.1 60.1 53.3 53.8 52.3
4102 96.1 97.3 98.1 96.0 94.9 94.2 80.2 56.0 55.7 61.0 60.8 60.6 60.6 52.6 53.2 52.3
Pgh3-2 97.4 95.5 95.5 95.4 95.7 95.7 80.2 56.0 55.9 60.6 60.8 60.0 60.0 53.3 53.6 51.8
M982 94.5 94.3 94.2 94.2 94.2 96.9 85.8
B:15, P1.16 95.1 94.3 93.5 93.6 95.1 96.7 80.5
B16B6 76.0 76.3 75.9 76.2 76.2 77.0 76.9
Q8 49.2 49.9 49.2 48.9 48.9
4223 48.7 49.2 48.1 48.6 48.8
DL63 51.7 52.0 52.0 52.4 52.6
PAK 51.6 52.1 52.0 52.3 52.6
MinnA 51.6 52.2 51.9 52.1 52.0
Eagan 51.6 52.2 51.9 52.1 52.0
h49 44.1 44.1 44.8 44.1 44.6
h171 44.7 44.4 45.0 44.4 45.3
h196 43.7 43.2 43.4 43.2 43.0
a Strains are grouped by genus and species using the following abbreviations: a, N. gonorrhoeae; b, N. meningitidis; c, M. catarrhalis; d, H. influenzae; e, A.
pleuropneumoniae; f, P. haemolytica. Percent similarity scores are shown in boldface; percent identity scores are shown in lightface.
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were raised in mice and screened by Western blotting against
iron-stressed, whole-cell lysates prepared from the wild-type
strain and from an isogenic tbpA mutant. Sera elicited against
peptides TbpA-2, TbpA-3, TbpA-5, and TbpA-6 recognized
TbpA specifically in this assay (Fig. 3). Those sera that were
negative by Western blotting were screened by ELISA to de-
termine whether the peptide elicited an immune response. All
sera reacted against homologous peptide in an ELISA format,
although the anti-TbpA-1 serum did so weakly and thus was
not further characterized. These results indicated that antibod-
ies elicited against peptides TbpA-1, TbpA-4, TbpA-7, and
TbpA-8, while not reactive against full-length TbpA, were ca-
pable of recognizing the immunizing peptide.
All antipeptide sera, with the exception of that raised against
TbpA-1, were screened by whole-cell dot blotting for reactivity
against whole, iron-stressed gonococci (Fig. 4). The only serum
that specifically reacted in this assay format was raised against
peptide TbpA-5 (Fig. 4). Due to the tendency of gonococci to
lyse, which could result in apparent surface exposure in dot
blots, we confirmed the dot blot result using immunofluores-
cence microscopy, in which the integrity of the reactive organ-
isms could be assessed by counterstain. As in the dot blot
experiment, antiserum raised against TbpA-5 was reactive by
this technique against whole, iron-stressed TbpA-expressing
gonococci but not against an isogenic tbpA mutant (data not
shown). These results indicated that the loop containing pep-
tide TbpA-5 was surface exposed. Counter to our original
hypothesis, antiserum raised against the other peptides did not
react with whole gonococci (Fig. 4), even though peptides
TbpA-3, TbpA-4, TbpA-6, TbpA-7, and TbpA-8 represented
epitopes that were predicted to be surface exposed. These sera
were likewise not reactive against TbpA expressed by FA6819
FIG. 3. Antigenic heterogeneity among gonococcal TbpA proteins. The Western blot contains iron-stressed, whole-cell lysates from the following gonococcal
strains: FA19, FA1090, UU1008, Pgh3-2, and FA6642 (lanes 1 to 5, respectively). Lanes 6 to 13 contain lysates from the following gonococcal strains obtained from
R. Brunham: 4102, 4121, 4125, 4141, 4146, 4178, 4196, and 4134, respectively. Lane 14 contains an iron-stressed, whole-cell lysate from meningococcal strain FAM20.
Blots were probed with antisera raised against TbpA-specific peptides as indicated at right. Blots were scanned with an HP ScanJet 4c and annotated with Adobe
Photoshop 4.0 software.
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in the absence of TbpB (data not shown); thus, the epitopes
represented by these peptides were not simply masked by the
presence of TbpB. However, it is possible that lipooligosaccha-
ride or some other surface structure could obstruct access by
antibody to TbpA even if the peptide-containing epitopes are
on the surface.
Using antipeptide sera to assess antigenic variability among
gonococci. A panel of 13 gonococcal strains and one meningo-
coccal strain (representative of the low-molecular-weight class)
was screened for reactivity with the four Western blot-positive
antipeptide sera. As noted previously (13), molecular mass
heterogeneity of TbpA among gonococci is limited to between
100 and 103 kDa (Fig. 3). All 13 gonococcal strains expressed
a TbpA that reacted with two of the antipeptide sera, those
elicited against TbpA-2 and TbpA-6 (Fig. 3). This result sug-
gested that the epitopes represented by these two peptides
were well conserved among the gonococcal strains tested. Sera
against peptide TbpA-3 reacted with TbpA from 2 out of 13
gonococcal strains, while sera against TbpA-5 reacted with
TbpA expressed by 6 out of 13 strains tested. None of the
antipeptide sera reacted with the low-molecular-weight TbpA
expressed by meningococcal strain FAM20 (Fig. 3, lane 14).
These observations are consistent with the sequence heteroge-
neity depicted in Fig. 1 in that the regions containing peptides
TbpA-3 and TbpA-5 were more variable than those containing
peptides TbpA-2 and TbpA-6.
DISCUSSION
Since the transferrin-binding proteins have been touted as
potential components of a vaccine (36, 50), it is important to
assess their interstrain antigenic and sequence variation in
addition to defining topology and surface exposure. Gonococ-
cal TbpBs (13) are more diverse than gonococcal TbpAs; how-
ever, they do not share the great diversity found among me-
ningococcal TbpBs (49). Meningococcal TbpBs fall into two
distinct classes based on molecular mass and sequence char-
acteristics. The low-molecular-weight family, consisting of ap-
proximately 26% of tested strains represented by strain B16B6,
expresses a TbpB protein of 68 kDa, while the high-molecular-
weight family, represented by strain M982, expresses a TbpB of
85 kDa (49). All tested gonococcal strains express a TbpB with
M982-like characteristics; there is no evidence of a B16B6-type
TbpB (13). In the current study, we assessed the sequence
variability of gonococcal TbpAs and found that they are very
similar to each other and equally similar to TbpAs of menin-
gococcal strains in the M982 family. In contrast, gonococcal
TbpAs share only 75% identity with the TbpA expressed by
meningococcal strain B16B6. This observation suggests that
both TbpB and TbpA proteins expressed by B16B6-type me-
ningococcal strains are distinct from those expressed by the
M982 family. That is, both transferrin-binding proteins can be
categorized into either high- or low-molecular-weight classes;
meningococcal strain B16B6, as the representative of the low-
molecular-weight class for which the sequences of TbpA and
TbpB are known, expresses a 68-kDa TbpB protein and a
distinct, although not markedly smaller, TbpA protein.
Sequence diversity among gonococcal TbpAs was largely
confined to four small regions that could be defined as hyper-
variable domains, by analogy with other neisserial antigens (12,
25, 26). Two of the four hypervariable domains were in the
vicinity of paired cysteine residues in gonococcal TbpA, again
reminiscent of another gonococcal antigen, pilin. In gonococ-
cal pilin, a characterized hypervariable region, also known as
minicassette 2, is flanked by conserved cysteine residues (25).
In addition to sequence variation, regions interspersed be-
tween putative transmembrane domains also contain all of the
length diversity detected by aligning 17 TbpA sequences from
a wide array of bacterial pathogens. The presence of both
length and sequence variation in these areas is consistent with
FIG. 4. Binding of antipeptide sera to whole, iron-stressed gonococcal cells. All strains tested in this analysis were derivatives of gonococcal strain FA19. Columns
of spots contain whole, iron-stressed cells (C) or total membrane preparations (M) of strain FA19 or FA6747, as indicated at top. Rows of spots were probed with
preimmune mouse serum (P) or hyperimmune serum (I) from mice immunized with peptides TbpA-2 through TbpA-8, as indicated on either side of the blot. Spots
in the lower right corner of the blot (labeled anti-Por) were probed with a PorA monoclonal antibody as a positive control. The blot was scanned with an HP ScanJet
4c and annotated with Adobe Photoshop 4.0 software.
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their topological assignment as either internal or external pu-
tative loops. Two of the antipeptide sera generated in this
study detected only a subset of gonococcal TbpAs. Consistent
with this observation, the sequences against which these sera
were raised lie within the above-defined hypervariable regions.
This suggests that TbpA-specific peptide antisera could be
used for serotyping, in a manner similar to those utilized cur-
rently in porin-specific serotyping schemes.
Stretches of sequence conservation among TbpAs are likely
to represent domains of the protein that are constrained by
common function or localization. In our alignment of 17 Tb-
pAs, the majority of sequence identity was found within or
slightly outside of regions that are homologous to character-
ized transmembrane b-strands in E. coli FepA (10). Strikingly,
none of the putative TbpA transmembrane domains contains
any length diversity, suggesting that maintenance of both
length and sequence identity is required for the structure
and/or function of these receptors. Other pockets of conserva-
tion include the putative plug region, which is not only con-
served among TbpAs but also well conserved among all mem-
bers of the TonB-dependent receptor family (10). Six cysteine
residues were also conserved among all TbpAs analyzed, al-
though the distance between the first and second cysteine res-
idues varied. Two pairs of cysteine residues were flanked by
hypervariable residues; in contrast, the third set of cysteines
was flanked by residues that were conserved among the gono-
cocci. Although all of the cysteine residues are likely to reside
in extracellular loops (10, 37, 51), it is unclear why some are
within apparent hypervariable regions while others are flanked
by conserved residues. Of note is the presence of a unique pair
of cysteine residues in P. haemolytica TbpA that coincides with
one of the four hypervariable regions. The presence of this pair
of cysteine residues strengthens our hypothesis that this hyper-
variable region (containing peptide TbpA-7) is located in an
extracellular loop.
By focusing on the putative loop regions interspersed be-
tween the transmembrane strands, we can identify several re-
gions that are distinct between the TbpAs expressed by the
human pathogens versus those expressed by the animal patho-
gens. These disparities might highlight epitopes that influence
the exquisite species specificity of these receptors. Thus, resi-
dues conserved among the TbpAs of human pathogens and
divergent in the TbpAs of the animal pathogens might be
critical for the specific binding of human transferrin. Residues
highlighted in gray in the alignment in Fig. 1 are unique to the
TbpAs that recognize human transferrin; therefore, these res-
idues might be critical for this interaction. Alternatively, these
residues could be conserved among the human pathogens be-
cause these pathogens are more closely related and thus the
proteins have not had the evolutionary time to diverge signif-
icantly. Another distinction between the TbpAs expressed by
the human and animal pathogens is found in both the length
and the sequence of the putative loop located between residues
577 and 758 in the alignment shown in Fig. 1. Excluding the
pair of cysteine residues, this entire putative loop is unique to
TbpAs expressed by the human pathogens. Interestingly, the
TbpA sequence of M. catarrhalis features four insertions within
this region, adding to the length diversity of this hypothetically
surface-exposed loop. The plasticity of this region, which also
coincides with the ligand-binding domain of E. coli FepA (45),
is consistent with surface exposure. Camouflaging conserved
epitopes with sequence and length diversity might be impor-
tant for evasion of an immune response raised against a re-
ceptor that is constrained by the necessity to bind one ligand.
The role, if any, that these differences between the TbpAs
expressed by human and animal pathogens play in receptor
specificity can be tested using current molecular techniques
including site-specific mutagenesis and binding-domain swap-
ping.
We initially generated peptide-specific antisera to probe the
topology of membrane-associated TbpA. The peptides synthe-
sized were hydrophilic and predicted to be surface exposed and
antigenic. While the peptides generated an immune response,
seven out of eight antipeptide sera did not recognize native
TbpA as presented in the context of the gonococcal outer
membrane. The antibodies elicited against peptide TbpA-5
represented the single exception to the poor cross-reactivity
between peptide and native protein epitopes. Antibodies gen-
erated against peptide TbpA-5 recognized both denatured and
native TbpA, supporting the hypothesis that the domain that
contains this peptide is surface accessible on intact gonococci.
The reason for the relative lack of cross-reactivity between the
antipeptide sera and native TbpA remains unclear. The pep-
tides synthesized in this study might have been too short to
adequately mimic the conformation of cell-surface-exposed
TbpA. Alternatively, cyclizing the peptide immunogens could
have increased the frequency with which we obtained sera
reactive against conformational epitopes. While this approach
was not particularly useful for direct topological mapping, the
antipeptide sera generated in this study were helpful in iden-
tification of antigenically diverse domains of TbpA. By analogy
with other gonococcal antigens, these hypervariable domains
are likely to be exposed to the immune system during the
course of infection (9). In addition, these peptide-specific an-
tisera could be useful serotyping reagents since they highlight
antigenic differences among gonococcal strains.
In this study, we compared the sequence and antigenic char-
acteristics of TbpA from a panel of gonococcal strains. Anti-
genic and sequence diversity among gonococcal isolates clus-
tered in hypervariable regions, which are postulated to be
surface exposed in the gonococcus. By comparing the TbpA
proteins expressed by a wide variety of bacterial pathogens, we
identified several conserved regions that are likely to be con-
fined by the common function and assembly of these receptors.
Many of the conserved domains overlap with areas that are
homologous to transmembrane b-strands in FepA. Other con-
served features include the amino-terminal 209 residues, a
sequence which is analogous to the plug region identified in
two crystallized TonB-dependent receptors (10, 37). Buchanan
et al. noted that the structure of this amino-terminal region
was unique among the TonB-dependent receptors and that the
coincidence of conservation and localization suggested that
these domains were crucial for the common function of these
receptors (10). Another conserved feature identified in the
current study of TbpAs was a series of paired cysteine residues,
which might be important for the topological stability of sev-
eral surface-exposed loops (10, 37, 51). Our ongoing studies
are aimed at dissection of the surface topology of the trans-
ferrin receptor and at delineation of surface-exposed, antigenic
domains of TbpA that might elicit a cross-reactive, protective
immune response.
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